Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Biochemical, pharmacologic and clinical properties of new thrombolytic agents].

Der Internist - 1 Jun 1996

Gulba D C

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fibrinolytic Agents
Share to Plasminogen Activators
Share to Recombinant Proteins
Share to Structure-Activity Relationship

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Thromboembolism

Share to Tissue Plasminogen Activator

Share to Treatment Outcome

Share to Urokinase-Type Plasminogen Activator

Source

Identifiers

PMID: 8767988

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Biochemical, pharmacologic and clinical properties of new thrombolytic agents].PMID 8767988Read ↗

Strategies for the improvement of thrombolytic agents.Semantic proximity Read ↗

[New types of plasminogen activators].Semantic proximity Read ↗

Pharmacological and clinical impact of the unique molecular structure of a new plasminogen activator.Semantic proximity Read ↗

Newer thrombolytic agents.Semantic proximity Read ↗

Properties of a novel plasminogen activator (BM 06.022) produced in Escherichia coli.Semantic proximity Read ↗

[Antithrombotic prophylaxis in pregnancy].Semantic proximity Read ↗

The potential improvement of thrombolytic therapy by targeting with bispecific monoclonal antibodies: why they are used and how they are made.Semantic proximity Read ↗

Tissue-type plasminogen activator: mutants, variants, and adjunctive treatment.Semantic proximity Read ↗

Thrombolytic properties in a rabbit jugular vein thrombosis model of a tissue-type plasminogen activator mutant lacking the growth factor--and kringle one-domains.Semantic proximity Read ↗

[Thrombin and its pharmacologic regulation].Semantic proximity Read ↗

A first-in-human study of the anti-inflammatory profibrinolytic TMS-007, an SMTP family triprenyl phenolSemantic proximity Read ↗

[Expression, purification and characterization of a novel staphylokinase with anti-platelet aggregation activity].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.